{"id":"NCT00658736","sponsor":"The Cleveland Clinic","briefTitle":"Efficacy of EUS-guided Celiac Plexus Blockade in Chronic Pancreatitis","officialTitle":"A Randomized, Triple-Blinded Study of Endoscopic Ultrasound Guided Celiac Plexus Blockade (EUS-CPB) With Bupivicaine and Triamcinolone vs. Bupivicaine Alone for the Treatment of Pain in Chronic Pancreatitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-03","primaryCompletion":"2011-01","completion":"2011-01","firstPosted":"2008-04-15","resultsPosted":"2017-06-14","lastUpdate":"2017-06-14"},"enrollment":40,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Pancreatitis"],"interventions":[{"type":"DRUG","name":"Triamcinolone","otherNames":[]},{"type":"DRUG","name":"Bupivicaine alone","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"This is a triple-blind, parallel group, randomized controlled trial to assess the benefit of triamcinolone injection as a therapeutic measure for control of chronic pancreatitis pain. The treatment group will undergo EUS-CPB with bupivicaine plus triamcinolone (\"therapeutic block\"). There control group will undergo EUS-CPB with bupivicaine alone (\"diagnostic block\").","primaryOutcome":{"measure":"Change in Pain Disability Index","timeFrame":"1 month after block","effectByArm":[{"arm":"Bupivicaine and Triamcinolone","deltaMin":3,"sd":null},{"arm":"Bupivicaine Alone","deltaMin":3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":21},"commonTop":["Abdominal pain","Hypertension urgency","Gastric hematoma"]}}